Lafayette Investments’s Gilead Sciences GILD Stock Holding History

Lafayette Investments’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,454	Closed	-$275K	–	153
2025 Q1	$275K	Sell	2,454 -250	-9%	-$25.8K	0.06%	128
2024 Q4	$250K	Sell	2,704 -231	-8%	-$20.8K	0.05%	131
2024 Q3	$246K	Hold	2,935	–	–	0.05%	130
2024 Q2	$201K	Hold	2,935	–	–	0.05%	136
2024 Q1	$215K	Hold	2,935	–	–	0.05%	130
2023 Q4	$238K	Buy	2,935 +250	+9%	+$19.5K	0.06%	116
2023 Q3	$201K	Hold	2,685	–	–	0.05%	123
2023 Q2	$207K	Hold	2,685	–	–	0.05%	120
2023 Q1	$223K	Hold	2,685	–	–	0.06%	111
2022 Q4	$231K	Buy	+2,685	New	+$213K	0.06%	106

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lafayette Investments's GILD Position: Q2 2025 in Review

Lafayette Investments sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 2,454 shares — an estimated $275K sold.

Lafayette Investments first reported a position in GILD in Q4 2022 and held it in 10 quarters. The position peaked at $275K in Q1 2025. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

Lafayette Investments reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
Lafayette Investments sold 2,454 Gilead Sciences shares in Q2 2025, an estimated $275K.
Lafayette Investments first reported a position in Gilead Sciences in Q4 2022 and held it in 10 quarters.
Lafayette Investments's Gilead Sciences position peaked at $275K in Q1 2025.
2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Lafayette Investments's 13F filing for Q2 2025, filed 30 Jul 2025.